Seeing Is Believing
Currently out of the existing stock ratings of Martin Auster, 128 are a BUY (68.82%), 48 are a HOLD (25.81%), 10 are a SELL (5.38%).
Analyst Martin Auster, carries an average stock price target met ratio of 65.62% that have a potential upside of 25.34% achieved within 202 days. Previously, Martin Auster worked at CREDIT SUISSE.
Martin Auster’s has documented 338 price targets and ratings displayed on 33 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ALNY, Alnylam Pharmaceuticals at 30-Oct-2025.
Analyst best performing recommendations are on ALXO (ALX ONCOLOGY HOLDINGS ).
The best stock recommendation documented was for ALXO (ALX ONCOLOGY HOLDINGS ) at 11/9/2020. The price target of $62 was fulfilled within 8 days with a profit of $15.41 (33.08%) receiving and performance score of 41.34.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-May-2021
$205
$22.5 (12.33%)
4 years 10 months 13 days ago
(05-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold Since 23-Mar-2021
$173
$-9.5 (-5.21%)
$156
4 years 10 months 15 days ago
(03-May-2021)
14/24 (58.33%)
$2.73 (1.60%)
682
Hold Since 14-Dec-2020
$190
4 years 10 months 20 days ago
(26-Apr-2021)
9/11 (81.82%)
$34.41 (22.12%)
350
Buy Since 06-Sep-2019
$175
$-7.5 (-4.11%)
$165
5 years 1 months 14 days ago
(04-Feb-2021)
3/3 (100%)
$19.41 (12.48%)
397
Hold Since 04-Feb-2021
$166
$-16.5 (-9.04%)
$175
5 years 1 months 14 days ago
(04-Feb-2021)
23/23 (100%)
$10.41 (6.69%)
828
Which stock is Martin Auster is most bullish on?
Which stock is Martin Auster is most reserved on?
What Year was the first public recommendation made by Martin Auster?